Singapore markets open in 7 hours 59 minutes
Straits Times Index
3,314.05 +0.57 (+0.02%) S&P 500
5,320.63 +17.36 (+0.33%) Dow
39,967.60 -35.99 (-0.09%) Nasdaq
16,818.30 +132.33 (+0.79%) Bitcoin USD
68,197.86 +1,489.10 (+2.23%) CMC Crypto 200
1,389.94 +35.52 (+2.63%)
NVO May 2024 135.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:49PM EDT. Market open.
| Previous close | 0.1800 |
| Open | 0.0400 |
| Bid | 0.0000 |
| Ask | 0.0100 |
| Strike | 135.00 |
| Expiry date | 2024-05-17 |
| Day's range | 0.0100 - 0.1500 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.98k |
BenzingaGenetic Profile Key To Novo Nordisk's Wegovy's Weight-Loss Effectiveness, Study Reveals
Researchers highlighted on Monday that certain genes may help identify patients with obesity who are most likely to respond strongly to Novo Nordisk A/S’s (NYSE:NVO) weight-loss drug Wegovy (semaglutide). The study, presented at the Digestive Disease Week meeting in Washington, found a 95% likelihood that patients with this genetic profile would be strong responders to the treatment. Related: Changing Frugal Eating Habits-How Novo Nordisk/Eli Lilly’s Weight Loss Drugs Reshaping Food Spending. Th
ZacksThe Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen
Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen are included in this Analyst Blog.
ZacksPharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
Bayer (BAYRY) releases Q1 results. J&J (JNJ) set to acquire private biotech, Proteologix, which will add atopic dermatitis candidates.
© 2024 Yahoo. All rights reserved.